Abstract
AbstractMucormycosis is an opportunistic, and frequently lethal, fungal infection that occurs in patients with immunocompromised states, such as diabetes mellitus. This infection invades not only the paranasal sinuses, but also the maxillae, zygoma, and rhinocerebral structures, which results in massive destruction of the facial skeleton and soft tissue. It progresses in patients with underlying comorbidities, such as diabetes mellitus, haematologic malignancy, cerebral malignancy, renal failure, and systemic immunosuppression. Most cases occur in tropical countries. The relationship between mucormycosis and these underlying conditions has been widely discussed in the literature. This study sought to report the case of a patient diagnosed with glioblastoma and mucormycosis in the maxilla, who was successfully treated with surgery and isavuconazonium sulfate (Cresemba).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
